Here we evaluate and discuss the expression levels of Raf-1 and MAPK (critical members of the MAPK cascade) and their activation status in matched HNPC and CRPC tumours and correlate expression levels with type 1 tyrosine kinase receptors, as well as their downstream targets, AR and AP-1, in the same cohort of patients. This evidence concerns the gene AR and neoplasm.